Results 171 to 180 of about 510,697 (405)

Vasculitis associated with psoriatic arthritis: a case report

Egyptian Rheumatology and Rehabilitation
Background Psoriatic arthritis is a chronic inflammatory condition associated with psoriasis, which affects joints. The coexistence of vasculitis, an inflammation of blood vessels, with psoriatic arthritis is rare, highlighting a complex interplay ...
Mehdi Jafarpour, Bita Rahbari, Bahareh Mehramuz, Sara Daneshvar   +3 more
doaj   +1 more source

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date. [PDF]

, 2018
Plaque psoriasis is an immune-mediated skin disease that affects roughly 3% of adults in the United States. Advances over the past 20 years in understanding the immune-mediated pathophysiology of psoriasis have led to the development of targeted biologic
Beck, Kristen M, Liao, Wilson, Sanchez, Isabelle M, Yang, Eric J   +3 more
core  

POS1068 DISCOVERY OF ARTHRITIS IN PSORIATIC PATIENTS FOR EARLY RHEUMATOLOGICAL REFERRAL (DAPPER): DEVELOPMENT OF A SCREENING TOOL FOR ACTIVE PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS [PDF]

, 2022
T. Van Hal, Michelle L M Mulder, Mark H. Wenink, J. M. P. A. van den Reek, E.M.G.J. de Jong   +4 more
openalex   +1 more source

The Effect of Social Media Intervention as a Reminder and Educational Tool to Increase Treatment Adherence in Patients With Psoriasis: A Randomized Controlled Trial

JEADV Clinical Practice, EarlyView.
In a 12‐week randomized trial of 159 psoriasis patients, educational messages and treatment reminders delivered through Facebook improved treatment adherence, reduced disease severity, and enhanced quality of life. Three times‐weekly messages provided the greatest benefits, including superior adherence, clearer skin, and higher patient satisfaction ...
Jennifer Lavina T. Ngo, Lily Lyralin L. Tumalad   +1 more
wiley   +1 more source

43356 Protective Effects of Biologics against Psoriatic Arthritis in Patients with Psoriasis [PDF]

, 2023
Shahin Shahsavari, Brendan Smith, Priya Engel   +2 more
openalex   +1 more source

Useful Instruments for Psoriasis Patients’ Follow‐Up in Teleconsultation Setting

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Teledermatology may be beneficial for psoriasis management and a working group of the International Psoriasis Council recently outlined the value of patient questionnaires in teledermatology. Objectives Identify instruments that could optimise psoriasis evaluation when completed before a teleconsultation; assess patients’ and ...
Emmanuel Mahé, Nicole Jouan, Delphine Devulder, Pascale Zukervar, Dorian Petonnet, Gaelle Desamericq, Theo Cerceau, Stéphane Bouée, Anne Bouloc   +8 more
wiley   +1 more source

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis

Biologics: Targets & Therapy, 2014
Dario Kivelevitch, Bobbak Mansouri, Alan Menter Department of Dermatology, Baylor University Medical Center, Dallas, TX, USA Abstract: Psoriasis is a chronic, immune-mediated inflammatory disease affecting both the skin and joints.
Kivelevitch D, Mansouri B, Menter A
doaj  

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

Serum C‐reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long‐term differential effects of biologics [PDF]

, 2015
Akihiko Asahina, Yoshinori Umezawa, Koichi Yanaba, Hidemi Nakagawa   +3 more
openalex   +1 more source

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard, Aaron Keal, James Hetherington, Sophie Barlow, David Wu, Melany Worbes‐Cerezo, Alexander Litvintchouk   +6 more
wiley   +1 more source